J.P. Morgan Private Wealth Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.81M | Buy |
+19,325
| New | +$1.81M | 0.01% | 776 |
|
|
2023
Q2 | – | Sell |
-12,929
| Closed | -$1.39M | – | 1497 |
|
|
2023
Q1 | $1.39M | Sell |
12,929
-104,394
| -89% | -$11.2M | ﹤0.01% | 1021 |
|
|
2022
Q4 | $14.3M | Buy |
117,323
+102,323
| +682% | +$12.5M | 0.03% | 357 |
|
|
2022
Q3 | $1.55M | Buy |
15,000
+2,215
| +17% | +$229K | ﹤0.01% | 939 |
|
|
2022
Q2 | $1.19M | Sell |
12,785
-920
| -7% | -$85.5K | ﹤0.01% | 1044 |
|
|
2022
Q1 | $1.61M | Sell |
13,705
-9,190
| -40% | -$1.08M | ﹤0.01% | 987 |
|
|
2021
Q4 | $3.08M | Buy |
22,895
+1,408
| +7% | +$189K | 0.01% | 764 |
|
|
2021
Q3 | $3.43M | Buy |
21,487
+4,220
| +24% | +$673K | 0.01% | 695 |
|
|
2021
Q2 | $2.27M | Buy |
17,267
+10,017
| +138% | +$1.32M | 0.01% | 821 |
|
|
2021
Q1 | $934K | Sell |
7,250
-70,538
| -91% | -$9.09M | ﹤0.01% | 1073 |
|
|
2020
Q4 | $13M | Buy |
77,788
+27,057
| +53% | +$4.51M | 0.04% | 329 |
|
|
2020
Q3 | $7.83M | Buy |
50,731
+46,229
| +1,027% | +$7.13M | 0.03% | 363 |
|
|
2020
Q2 | $666K | Buy |
+4,502
| New | +$666K | ﹤0.01% | 964 |
|